Charles River Laboratories International (STU:RV6) FCF Margin %: -1.49% (As of Mar. 2026)


STU:RV6 Charles River Laboratories International Inc STU:RV6
68 GF Score
Price €188.50
GF Value €170.09
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Charles River Laboratories International FCF Margin %?

Charles River Laboratories International STU:RV6 +1.32% 68 FCF Margin % is -1.49% as of Mar. 2026. GuruFocus rates STU:RV6 with a GF Score™ of 68/100 and a GF Value™ of €170.09 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Charles River Laboratories International ranks better than 74.88% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Charles River Laboratories International's Free Cash Flow for the three months ended in Mar. 2026 was €-13 Mil. Charles River Laboratories International's Revenue for the three months ended in Mar. 2026 was €861 Mil. Therefore, Charles River Laboratories International's FCF Margin % for the quarter that ended in Mar. 2026 was -1.49%.

As of today, Charles River Laboratories International's current FCF Yield % is 3.77%.

The historical rank and industry rank for Charles River Laboratories International's FCF Margin % or its related term are showing as below:

STU:RV6' s FCF Margin % Range Over the Past 10 Years
Min: 7.42   Med: 12.95   Max: 15.56
Current: 9.7


During the past 13 years, the highest FCF Margin % of Charles River Laboratories International was 15.56%. The lowest was 7.42%. And the median was 12.95%.

STU:RV6's FCF Margin % is ranked better than
74.88% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.89 vs STU:RV6: 9.70


Charles River Laboratories International FCF Margin % Related Terms


Charles River Laboratories International FCF Margin % Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International FCF Margin % Chart

Charles River Laboratories International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.03 7.42 8.85 12.39 12.91

Charles River Laboratories International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.42 16.40 17.74 5.89 -1.49

STU:RV6 vs RVTY, QGEN, ICLR: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Charles River Laboratories International's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's FCF Margin % falls into.


STU:RV6
68GF Score
Charles River Laboratories International Inc STU:RV6
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Charles River Laboratories International's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=442.794/3429.136
=12.91 %

Charles River Laboratories International's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-12.828/861.393
=-1.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -1.49% mean?
Charles River Laboratories International (STU:RV6) has a FCF Margin % of -1.49% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Charles River Laboratories International and its competitors. Over the past decade, Charles River Laboratories International's FCF Margin % has ranged from 7.42 to 15.56. According to the industry distribution chart, Charles River Laboratories International ranks #51 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 25.1%.
Is Charles River Laboratories International's FCF Margin % too high?
Charles River Laboratories International's current FCF Margin % is -1.49%. Over the past 10 years, this metric has ranged from a low of 7.42 to a high of 15.56. Based on the distribution chart, Charles River Laboratories International ranks #51 out of 203 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Charles River Laboratories International has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's FCF Margin % compare to RVTY and QGEN?
According to the Medical Diagnostics & Research industry distribution chart, Charles River Laboratories International ranks #51 out of 203 companies for FCF Margin %. This puts Charles River Laboratories International in the upper half of its industry. Historically, Charles River Laboratories International's own FCF Margin % has ranged from 7.42 to 15.56 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Charles River Laboratories International and its competitors. Charles River Laboratories International's current FCF Margin % is -1.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Based on GuruFocus' analysis, Charles River Laboratories International (STU:RV6) is currently considered Modestly Overvalued. The stock's GF Value™ is €170.09, compared to a current price of €188.50 — trading 10.8% above its estimated fair value. The current FCF Margin % is -1.49%. Charles River Laboratories International's overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Charles River Laboratories International (STU:RV6), the current FCF Margin % is -1.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (STU:RV6) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of €188.50 is trading 10.8% above its estimated GF Value™ of €170.09. GuruFocus considers Charles River Laboratories International to be Modestly Overvalued.

Key valuation signals for STU:RV6:

  • FCF Margin %: -1.49%
  • GF Value™: €170.09 vs. price of €188.50 (10.8% above fair value)
  • GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the STU:RV6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
68GF Score

Get the complete analysis for STU:RV6

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€188.50
Price
€170.09
GF Value